Interface Biologics develops transformative biomedical polymer technology for use in medical devices... Read more
Interfacebiologics President & CEO: Tom Reeves

President & CEO

Tom Reeves

CEO Approval Rating

69/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$12M

News

Jan 14, 2020
FinanzNachrichten
Interfacebiologics: Interface Biologics Inc.: Interface Biologics Announces Spinout, Ripple Therapeutics
Sep 03, 2019
MarketScreener
Interfacebiologics: Evonik Industries : acquires a surface modification technology platform from Interface Biologics to further expand its medical device capabilities
Dec 04, 2018
GlobeNewswire
Press Release: Interfacebiologics : Interface Biologics Announces New V.P., Business Development
Nov 27, 2018
GlobeNewswire
Press Release: Interfacebiologics : Interface Biologics Completes Pre-IND Meeting with U.S. FDA on Epidel® Technology for treatment of Posterior Inflammatory Eye Diseases
Nov 23, 2018
BioPortfolio
Interfacebiologics: Interface Biologics Inc Medical Equipment Deals and Alliances Profile Report Updated 15102018 Prices from USD $250
Sep 09, 2018
BioPortfolio
Interfacebiologics: Interface Biologics Inc Medical Equipment Deals and Alliances Profile Report Updated 11052018 Prices from USD $250
Feb 14, 2018
BioPortfolio
IBI: Interface Biologics Inc Medical Equipment Deals and Alliances Profile Report Updated 08022018 Prices from USD $250
Oct 18, 2017
BioPortfolio
IBI: Interface Biologics Inc Medical Equipment Deals and Alliances Profile Report Updated 12102017 Prices from USD $250
Aug 21, 2017
BioPortfolio
IBI: Interface Biologics Inc. Medical Equipment Deals and Alliances Profile Report Updated 12072017 Prices from USD $250
Apr 25, 2017
BizPR
Press Release: IBI : Interface Biologics, Inc. - Medical Equipment - Deals and Alliances Profile overview.

Trending Companies